PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate- a Facility-Level Cost-Offset Model Under the Medicare Bundle
Abstract
Authors
R. Mutell J.L. Rubin T.C. Bond T. Mayne